Amino acid compounds and methods of use
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- PLIANT THERAPEUTICS INC
- Publication Date
- 2021-07-30
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims the benefit of priority to U.S. Provisional Patent Application Serial No. 62 / 742,901, filed October 8, 2018, the entire contents of which are incorporated herein by reference. technical field
[0003] The present disclosure generally relates to therapeutic agents useful as inhibitors of αvβ6 integrins. The therapeutic agents are useful in the treatment or prevention of fibrosis, such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). Background technique
[0004] Fibrosis, a pathological feature of many diseases, results from a malfunction in the body's natural ability to repair damaged tissue. If left untreated, fibrosis can lead to scarring of vital organs, causing irreparable damage and eventual organ failure.
[0005] Patients with nonalcoholic fatty liver disease (NAFLD) may progress from pure steatosis to nonalcoholic steatohepatitis (NASH) with subseq...